NASDAQ:CUTR - Cutera Stock Price, Forecast & News Adding Choose a watchlist: Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat Daily Premium to add more stocks to your watchlist. Adding Cutera, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Log In and Add $33.91 -0.88 (-2.53 %) (As of 01/17/2020 04:00 PM ET) Add Compare Today's Range$33.46Now: $33.91▼$34.6350-Day Range$34.77MA: $36.70▼$38.6952-Week Range$13.10Now: $33.91▼$39.15Volume19,861 shsAverage Volume150,250 shsMarket Capitalization$482.64 millionP/E RatioN/ADividend YieldN/ABeta0.94 ProfileAnalyst RatingsAdvanced ChartEarningsFinancialsInsider TradesInstitutional OwnershipHeadlinesOptions ChainSEC FilingsSocial Media Share on FacebookShare on TwitterShare on LinkedInShare on RedditShare on StocktwitsPrint this articleShare by Email Cutera, Inc, a medical device company, designs, develops, manufactures, markets, and services laser and other energy based aesthetics systems worldwide. The company offers enlighten platform, a laser system that is used for tattoo removal, as well as for the treatment of benign pigmented lesions; excel HR platform, a hair removal solution for various skin types; and truSculpt, a high-powered radio frequency platform designed for deep tissue heating. Read More… Industry, Sector and Symbol Stock Exchange NASDAQ Industry Electromedical equipment Sub-IndustryN/A SectorComputer and Technology Current SymbolNASDAQ:CUTR Previous Symbol CUSIPN/A CIK1162461 Webhttp://www.cutera.com/ Phone415-657-5500Debt Debt-to-Equity Ratio0.18 Current Ratio1.66 Quick Ratio1.05Price-To-Earnings Trailing P/E RatioN/A Forward P/E RatioN/A P/E GrowthN/A Sales & Book Value Annual Sales$162.72 million Price / Sales2.97 Cash FlowN/A Price / Cash FlowN/A Book Value$3.34 per share Price / Book10.15Profitability EPS (Most Recent Fiscal Year)($2.23) Net Income$-30,770,000.00 Net Margins-20.84% Return on Equity-84.67% Return on Assets-35.30%Miscellaneous Employees402 Outstanding Shares14,233,000Market Cap$482.64 million Next Earnings Date2/19/2020 (Estimated) OptionableOptionable Receive CUTR News and Ratings via Email Sign-up to receive the latest news and ratings for CUTR and its competitors with MarketBeat's FREE daily newsletter. NASDAQ:CUTR Rates by TradingView Cutera (NASDAQ:CUTR) Frequently Asked Questions What is Cutera's stock symbol? Cutera trades on the NASDAQ under the ticker symbol "CUTR." How were Cutera's earnings last quarter? Cutera, Inc. (NASDAQ:CUTR) posted its quarterly earnings results on Thursday, November, 7th. The medical device company reported $0.15 earnings per share for the quarter, beating the consensus estimate of ($0.08) by $0.23. The medical device company earned $46.12 million during the quarter, compared to analysts' expectations of $41.66 million. Cutera had a negative net margin of 20.84% and a negative return on equity of 84.67%. The business's revenue for the quarter was up 13.7% on a year-over-year basis. During the same quarter in the prior year, the company posted $0.11 EPS. View Cutera's Earnings History. When is Cutera's next earnings date? Cutera is scheduled to release their next quarterly earnings announcement on Wednesday, February 19th 2020. View Earnings Estimates for Cutera. What guidance has Cutera issued on next quarter's earnings? Cutera updated its FY 2019 Pre-Market earnings guidance on Monday, January, 13th. The company provided earnings per share (EPS) guidance of for the period. The company issued revenue guidance of $180.9-181.9 million, compared to the consensus revenue estimate of $178.96 million. What price target have analysts set for CUTR? 3 brokers have issued 12 month price targets for Cutera's stock. Their forecasts range from $45.00 to $45.00. On average, they anticipate Cutera's share price to reach $45.00 in the next twelve months. This suggests a possible upside of 32.7% from the stock's current price. View Analyst Price Targets for Cutera. What is the consensus analysts' recommendation for Cutera? 3 Wall Street analysts have issued "buy," "hold," and "sell" ratings for Cutera in the last year. There are currently 2 hold ratings and 1 buy rating for the stock, resulting in a consensus recommendation of "Hold." View Analyst Ratings for Cutera. What are Wall Street analysts saying about Cutera stock? Here are some recent quotes from research analysts about Cutera stock: 1. According to Zacks Investment Research, "Cutera Inc designs, develops, manufactures and markets the CoolGlide family of products for use in laser and other light-based aesthetic applications. The original CoolGlide CV provides permanent hair reduction on all skin types. The second generation CoolGlide Excel incorporated features that added the capability to treat a variety of vascular lesions, which include facial telangiectasia, spider and reticular leg veins. The CoolGlide Vantage added non-ablative skin therapy to the range of applications offered by the system. " (1/10/2020) 2. Maxim Group analysts commented, "Market close, CUTR reported better-than-expected 2Q19 revenue, earnings, and gross margin compared to both Maxim and consensus estimates. Due to strong sales during the quarter and higher expected gross margins going forward, we are increasing our 2019 and 2020 revenue and GAAP EPS estimates. Management reiterated 2019 guidance for revenue, gross margins, and adjusted EBITDA, which we believe may now be too conservative in terms of revenue. We are also introducing quarterly estimates for 2020." (8/9/2019) Has Cutera been receiving favorable news coverage? Media headlines about CUTR stock have trended somewhat positive recently, InfoTrie Sentiment Analysis reports. The research group identifies negative and positive press coverage by reviewing more than six thousand news and blog sources in real-time. The firm ranks coverage of companies on a scale of negative five to five, with scores closest to five being the most favorable. Cutera earned a news impact score of 0.7 on InfoTrie's scale. They also assigned news stories about the medical device company a news buzz of 10.0 out of 10, meaning that recent press coverage is extremely likely to have an effect on the stock's share price in the next few days. View News Stories for Cutera. Who are some of Cutera's key competitors? Some companies that are related to Cutera include InMode (INMD), Natus Medical (NTUS), AxoGen (AXGN), TransMedics Group (TMDX), Zynex (ZYXI), Stereotaxis (STXS), Semler Scientific (SMLR), BioLife Solutions (BLFS), Viewray (VRAY), Rockwell Medical (RMTI), Fonar (FONR), Soleno Therapeutics (SLNO), BioSig Technologies (BSGM), Edap Tms (EDAP) and Second Sight Medical Products (EYES). What other stocks do shareholders of Cutera own? Based on aggregate information from My MarketBeat watchlists, some companies that other Cutera investors own include Micron Technology (MU), AbbVie (ABBV), Alibaba Group (BABA), Pfizer (PFE), Biogen (BIIB), Celgene (CELG), Clovis Oncology (CLVS), Corcept Therapeutics (CORT), Costco Wholesale (COST) and Exelixis (EXEL). Who are Cutera's key executives? Cutera's management team includes the folowing people: Ms. Sandra A. Gardiner, Exec. VP & CFO (Age 53)Mr. Larry E. Laber, Exec. VP of Sales - North America (Age 48)Mr. Ronald J. Santilli, Exec. Officer (Age 59)Mr. Jason Richey, Interim CEO & Chief Operating OfficerDr. Michael Karavitis, Exec. VP & Chief Technology Officer Who are Cutera's major shareholders? Cutera's stock is owned by many different of institutional and retail investors. Top institutional shareholders include Calamos Advisors LLC (1.05%) and Wedge Capital Management L L P NC (0.18%). Company insiders that own Cutera stock include David A Gollnick, Gregory A Barrett, J Daniel Plants, James A Reinstein and Larry Laber. View Institutional Ownership Trends for Cutera. Which institutional investors are selling Cutera stock? CUTR stock was sold by a variety of institutional investors in the last quarter, including Wedge Capital Management L L P NC. View Insider Buying and Selling for Cutera. Which institutional investors are buying Cutera stock? CUTR stock was acquired by a variety of institutional investors in the last quarter, including Calamos Advisors LLC. Company insiders that have bought Cutera stock in the last two years include Gregory A Barrett, J Daniel Plants and James A Reinstein. View Insider Buying and Selling for Cutera. How do I buy shares of Cutera? Shares of CUTR can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity and Charles Schwab. What is Cutera's stock price today? One share of CUTR stock can currently be purchased for approximately $33.91. How big of a company is Cutera? Cutera has a market capitalization of $482.64 million and generates $162.72 million in revenue each year. The medical device company earns $-30,770,000.00 in net income (profit) each year or ($2.23) on an earnings per share basis. Cutera employs 402 workers across the globe.View Additional Information About Cutera. What is Cutera's official website? The official website for Cutera is http://www.cutera.com/. How can I contact Cutera? Cutera's mailing address is 3240 BAYSHORE BOULEVARD, BRISBANE CA, 94005. The medical device company can be reached via phone at 415-657-5500 or via email at [email protected] MarketBeat Community Rating for Cutera (NASDAQ CUTR)Community Ranking: 2.6 out of 5 ( )Outperform Votes: 288 (Vote Outperform)Underperform Votes: 265 (Vote Underperform)Total Votes: 553MarketBeat's community ratings are surveys of what our community members think about Cutera and other stocks. Vote "Outperform" if you believe CUTR will outperform the S&P 500 over the long term. Vote "Underperform" if you believe CUTR will underperform the S&P 500 over the long term. You may vote once every thirty days. This page was last updated on 1/17/2020 by MarketBeat.com StaffFeatured Article: Why is the price-sales ratio important?
